Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00003299 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

587

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: etoposide
DRUG: paclitaxel

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]